Breakfast With the Experts: Updates in the Management of Patients With Metastatic Castration-Resistant Prostate Cancer

Learn how experts incorporate new and established therapies into optimal management of metastatic castration-resistant prostate cancer with these downloadable slides and commentary answering healthcare professionals&rsquo questions from a live webinar.

Share

Program Content

No activities added yet

Activities

mCRPC: Current Therapy
Case Discussion: Overview of the Current Treatment Landscape for mCRPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

Combination Therapy
Case Discussion: Investigating Approved Therapies in New Settings in mCRPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

mCRPC Novel Tx
Case Discussion: Advances in Systemic and Targeted Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

Activities

Expert FAQ on mCRPC
Experts Answer Questions on Managing mCRPC in a Rapidly Evolving Disease Paradigm
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2022

Expires: March 13, 2023

Faculty

cover img faculity

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

cover img faculity

Michael Schweizer, MD

Associate Professor
Clinical Research Division
Department of Medical Oncology
University of Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

Matthew R. Smith, MD, PhD

Professor of Medicine
Harvard Medical School
Director
Genitourinary Malignancies Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Novartis Pharmaceuticals Corp Advanced Accelerator Applications

Sanofi Genzyme